Cosmos Health (COSM) Short term Debt (2013 - 2026)
Cosmos Health's (COSM) quarterly Short term Debt came in at $8.7 million in Q2 2026, up 7.15% on a YoY basis from $8.2 million in Q2 2025, and up 11.32% quarter-over-quarter from $7.9 million in Q1 2026.
Analysis
Cosmos Health (COSM) Short term Debt (2013 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Short term Debt for 14 consecutive years, with $8.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Short term Debt rose 7.15% year-over-year to $8.7 million; the trailing twelve-month figure through Jun 2026 stood at $8.7 million (up 7.15% YoY), and the FY2025 full-year result was $9.2 million, up 31.39% from the prior year.
- Short term Debt improved to $8.7 million in Q2 2026 per COSM's latest filing, from $7.9 million in the prior quarter.
- Across five years, Short term Debt topped out at $12.1 million in Q2 2022 and bottomed at $4.7 million in Q1 2023.
- Historically, Short term Debt has averaged $7.0 million across 5 years, with a median of $6.8 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Short term Debt soared 1481.28% in 2022, then plunged 61.01% in 2023.
- Over 5 years, Short term Debt stood at $5.8 million in 2022, then gained by 15.13% to $6.6 million in 2023, then grew by 5.35% to $7.0 million in 2024, then soared by 31.39% to $9.2 million in 2025, then fell by 4.71% to $8.7 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $8.7 million, $7.9 million, and $9.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.75 Mn |
| Mar 31, 2026 | 7.86 Mn |
| Dec 31, 2025 | 9.18 Mn |
| Sep 30, 2025 | 7.58 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | 7.31 Mn |
| Dec 31, 2024 | 6.99 Mn |
| Sep 30, 2024 | 5.99 Mn |
| Jun 30, 2024 | 7.11 Mn |
| Mar 31, 2024 | 6.43 Mn |
| Dec 31, 2023 | 6.63 Mn |
| Sep 30, 2023 | 5.35 Mn |
| Jun 30, 2023 | 4.73 Mn |
| Mar 31, 2023 | 4.71 Mn |
| Dec 31, 2022 | 5.76 Mn |
| Sep 30, 2022 | 4.92 Mn |
| Jun 30, 2022 | 12.12 Mn |
| Mar 31, 2022 | 6.14 Mn |
| Dec 31, 2021 | 12.13 Mn |
| Jun 30, 2021 | 766,496.00 |